Journal
EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY
Volume 10, Issue 11, Pages 1257-1269Publisher
TAYLOR & FRANCIS LTD
DOI: 10.1080/17474124.2016.1241708
Keywords
Crohn's disease; post-operative Crohn's disease; biologics; anti-TNF agents; endoscopic scoring system
Categories
Ask authors/readers for more resources
Introduction: Postoperative recurrence (POR) of Crohn's disease is common after surgical resection. How to best manage POR remains uncertain.Areas covered: In this review, we will first describe the natural course and the best modalities to diagnose this surgical sequela. We will then focus on the potential risk factors for relapse and highlight the main shortcomings in the current study designs and endoscopic and clinical scoring systems, which may partly explain the unexpected outcomes of recent clinical trials. Finally, we will propose a strategy to address the management of POR.Expert commentary: Anti-tumor necrosis factor (Anti-TNF) agents are the most effective therapy to prevent POR in Crohn's disease. Patient risk stratification and active monitoring with scheduled ileocolonoscopy are cornerstones of optimal POR management. Further studies are needed to address areas of uncertainty including timing and duration of therapy and the role of therapeutic drug monitoring in this setting.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available